| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1089/DNA.2006.0550 |
| P698 | PubMed publication ID | 17504027 |
| P2093 | author name string | Tomoki Naoe | |
| Yoshihito Nakagawa | |||
| Yukihiro Akao | |||
| P2860 | cites work | The colorectal microRNAome | Q29616082 |
| Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues | Q34997758 | ||
| P433 | issue | 5 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 311-320 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | DNA and Cell Biology | Q5205740 |
| P1476 | title | MicroRNA-143 and -145 in colon cancer | |
| P478 | volume | 26 |
| Q32183014 | A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells |
| Q35666571 | A microRNA molecular modeling extension for prediction of colorectal cancer treatment |
| Q35997446 | A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis |
| Q26998025 | Alterations of microRNAs contribute to colon carcinogenesis |
| Q37184148 | Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG. |
| Q24648360 | Altered microRNA Expression Patterns in Hepatoblastoma Patients |
| Q41765214 | Anti-cancer effects of xanthones from pericarps of mangosteen |
| Q35878356 | Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. |
| Q33947056 | Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma |
| Q38228503 | Autophagy and microRNA dysregulation in liver diseases |
| Q34205596 | Biomarkers for Colorectal Cancer |
| Q64084852 | Bipartite Heterogeneous Network Method Based on Co-neighbor for MiRNA-Disease Association Prediction |
| Q39242784 | Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts |
| Q24646844 | Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
| Q55119635 | Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review. |
| Q35562931 | Circulating microRNAs as potential biomarkers for endometriosis |
| Q35101445 | Co-modulated behavior and effects of differentially expressed miRNA in colorectal cancer |
| Q36529740 | Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer |
| Q36298188 | DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma |
| Q43539336 | Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer |
| Q35854294 | Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC. |
| Q38029108 | Drug resistance-related microRNAs in esophageal cancer |
| Q37285463 | EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators |
| Q24598045 | Epigenetics of colorectal cancer |
| Q64096570 | Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo |
| Q36524796 | Expression profiling of selected microRNA signatures in plasma and tissues of Saudi colorectal cancer patients by qPCR. |
| Q38228678 | From miRNA regulation to miRNA-TF co-regulation: computational approaches and challenges |
| Q34126628 | High-throughput functional microRNAs profiling by recombinant AAV-based microRNA sensor arrays |
| Q37400076 | Highly sensitive dual mode electrochemical platform for microRNA detection |
| Q36761209 | Hsa-miR-590-5p Interaction with SMAD3 Transcript Supports Its Regulatory Effect on The TGFβ Signaling Pathway |
| Q34876165 | Identification and characterization of progesterone- and estrogen-regulated MicroRNAs in mouse endometrial epithelial cells. |
| Q21245713 | Identification of non-coding RNAs embracing microRNA-143/145 cluster |
| Q34368313 | Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation |
| Q37497803 | Identifying miRNAs, targets and functions. |
| Q35565247 | Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics |
| Q36417421 | Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway |
| Q36173829 | Inhibition of autophagy and tumor growth in colon cancer by miR-502. |
| Q36356414 | Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft. |
| Q53656768 | Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer. |
| Q52597053 | Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. |
| Q36336831 | Mechanistic aspects of COX-2 expression in colorectal neoplasia |
| Q37806613 | Metastamirs: a stepping stone towards improved cancer management |
| Q42805232 | MiR-143 enhances adipogenic differentiation of 3T3-L1 cells through targeting the coding region of mouse pleiotrophin |
| Q50884607 | MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer. |
| Q36922953 | MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6. |
| Q33779355 | MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells |
| Q42251339 | MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells |
| Q24630357 | MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network |
| Q24632636 | MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer |
| Q34733682 | MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1 |
| Q53319872 | MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. |
| Q33344505 | MicroRNA expression and identification of putative miRNA targets in ovarian cancer |
| Q37924177 | MicroRNA replacement therapy for cancer |
| Q39787288 | MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells |
| Q34301072 | MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells |
| Q35008686 | MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. |
| Q33555201 | MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1. |
| Q37071996 | MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells |
| Q21142669 | MicroRNA-145 targets YES and STAT1 in colon cancer cells |
| Q34964080 | MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. |
| Q33644599 | MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer |
| Q28256145 | MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1 |
| Q37646533 | MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma |
| Q40575902 | MicroRNAs - Important Molecules in Lung Cancer Research |
| Q34144188 | MicroRNAs and Their Therapeutic Potential for Human Diseases: MicroRNAs, miR-143 and -145, Function as Anti-oncomirs and the Application of Chemically Modified miR-143 as an Anti-cancer Drug |
| Q45944835 | MicroRNAs and complex diseases: from experimental results to computational models. |
| Q37103613 | MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications |
| Q33713311 | MicroRNAs and the regulation of vector tropism |
| Q34162262 | MicroRNAs as Biomarkers in Colorectal Cancer |
| Q38288967 | MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis |
| Q36553661 | MicroRNAs as potential biomarkers in human solid tumors |
| Q37827156 | MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors |
| Q48334926 | MicroRNAs in cancer: personalizing diagnosis and therapy |
| Q37227489 | MicroRNAs in solid tumors |
| Q37374567 | MicroRNAs in the ontogeny of leukemias and lymphomas |
| Q24618771 | MicroRNAs: control and loss of control in human physiology and disease |
| Q34326553 | MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential |
| Q39294200 | Mitochondrial determinants of cancer health disparities |
| Q42445312 | Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells |
| Q34521714 | Multifaceted enrichment analysis of RNA-RNA crosstalk reveals cooperating micro-societies in human colorectal cancer |
| Q38826546 | Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients |
| Q38031834 | Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer |
| Q47131773 | Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer |
| Q53319620 | Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. |
| Q30583504 | PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data |
| Q26782530 | Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis |
| Q24632934 | Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene |
| Q36034189 | RBMMMDA: predicting multiple types of disease-microRNA associations |
| Q37330849 | RETRACTED: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma |
| Q48145593 | Regulated Polarization of Tumor-Associated Macrophages by miR-145 via Colorectal Cancer-Derived Extracellular Vesicles |
| Q34094203 | Role of anti-oncomirs miR-143 and -145 in human colorectal tumors |
| Q52958113 | Salivary microRNAs in oral cancer. |
| Q33938849 | Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma |
| Q92727723 | Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo |
| Q33787478 | The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis |
| Q34519505 | The differential expression of microRNA-143,145 in endometriosis. |
| Q37415431 | The impact of microRNAs on colorectal cancer |
| Q35642150 | The murine caecal microRNA signature depends on the presence of the endogenous microbiota |
| Q34219266 | The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer |
| Q36096641 | The role of microRNAs in colorectal cancer |
| Q99584692 | The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent |
| Q43717784 | Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment |
| Q55470742 | lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line. |
| Q46114858 | miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer |
| Q38340387 | miR-106a–mediated Malignant Transformation of Cells Induced by Anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide |
| Q39105813 | miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells |
| Q58302564 | miR-143 inhibits proliferation and induces apoptosis of mammary epithelial cells in dairy goat |
| Q21142723 | miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice |
| Q24650959 | miR-145 directs intestinal maturation in zebrafish |
| Q35001206 | miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells |
| Q52655160 | miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade. |
| Q35556332 | miR-21 and miR-145 cooperation in regulation of colon cancer stem cells |
| Q52641287 | miR-590-3p mediates melatonin-induced cell apoptosis by targeting septin 7 in the human osteoblast cell line hFOB 1.19. |
| Q34393268 | miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc |
| Q37750843 | miRNAs as molecular biomarkers of cancer |
| Q43040562 | miRNAs in precancerous lesions of the gastrointestinal tract |
| Q39197874 | socs7, a target gene of microRNA-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells |
Search more.